Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection

Virology
Darren S MillerAllison R Jilbert

Abstract

Short-term antiviral therapy with the nucleoside analogue entecavir (ETV), given at an early stage of duck hepatitis B virus (DHBV) infection, restricts virus spread and leads to clearance of DHBV-infected hepatocytes in approximately 50% of ETV-treated ducks, whereas widespread and persistent DHBV infection develops in 100% of untreated ducks. To increase the treatment response rate, ETV treatment was combined in the current study with a post-exposure "prime-boost" vaccination protocol. Four groups of 14-day-old ducks were inoculated intravenously with a dose of DHBV previously shown to induce persistent DHBV infection. One hour post-infection (p.i.), ducks were primed with DNA vaccines that expressed DHBV core (DHBc) and surface (pre-S/S and S) antigens (Groups A, B) or the DNA vector alone (Groups C, D). ETV (Groups A, C) or water (Groups B, D) was simultaneously administered by gavage and continued for 14 days. Ducks were boosted 7 days p.i. with recombinant fowlpoxvirus (rFPV) strains also expressing DHBc and pre-S/S antigens (Groups A, B) or the FPV-M3 vector (Groups C, D). DHBV-infected hepatocytes were observed in the liver of all ducks at day 4 p.i. with reduced numbers in the ETV-treated ducks. Ducks treated with ETV ...Continue Reading

References

Aug 1, 1990·Virus Research·M QiaoC J Burrell
Jun 1, 1988·Virus Research·D B Boyle, B E Coupar
Apr 1, 1995·Clinical Immunology and Immunopathology·J F TsaiJ H Tsai
Oct 1, 1993·Immunology and Cell Biology·D B Boyle, H G Heine
Jan 1, 1997·Archives of Virology·D B BoyleB E Coupar
Dec 3, 1999·Immunological Reviews·A J RamsayI A Ramshaw
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R ErenS Dagan
Feb 13, 2001·The Journal of General Virology·M TriyatniA Jilbert
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eithan GalunShlomo Dagan
Jun 25, 2003·Journal of Hepatology·Antonio Bertoletti, Nikolai V Naoumov
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Antonio Bertoletti, Carlo Ferrari
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Wendy K FosterAllison R Jilbert
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Monika van ZonneveldHarry L A Janssen
Apr 28, 2005·Developmental and Comparative Immunology·Sonja KothlowUrsula Schultz
Nov 1, 2005·Vaccine·Barbara E H CouparDavid B Boyle
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hyung Joon Yim, Anna Suk-Fong Lok
Mar 10, 2006·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN BEHoLD AI463027 Study Group
Mar 10, 2006·The New England Journal of Medicine·Jay H Hoofnagle

❮ Previous
Next ❯

Citations

Jun 2, 2012·World Journal of Gastroenterology : WJG·Yukihiro Shimizu
Dec 2, 2015·Vaccine·Marine MeunierDaniel Dory
Aug 14, 2013·Antimicrobial Agents and Chemotherapy·Faseeha NoordeenAllison R Jilbert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.